Trials / Completed
CompletedNCT06309212
Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,197 (actual)
- Sponsor
- Acibadem University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.
Detailed description
Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay |
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2023-12-30
- Completion
- 2024-01-30
- First posted
- 2024-03-13
- Last updated
- 2024-03-13
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06309212. Inclusion in this directory is not an endorsement.